228 related articles for article (PubMed ID: 32273762)
1. Genetic Characterization and Risk Stratification of Acute Myeloid Leukemia.
Pourrajab F; Zare-Khormizi MR; Hashemi AS; Hekmatimoghaddam S
Cancer Manag Res; 2020; 12():2231-2253. PubMed ID: 32273762
[TBL] [Abstract][Full Text] [Related]
2. Molecular biomarkers in acute myeloid leukemia.
Prada-Arismendy J; Arroyave JC; Röthlisberger S
Blood Rev; 2017 Jan; 31(1):63-76. PubMed ID: 27639498
[TBL] [Abstract][Full Text] [Related]
3. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
Mandelli F; Petti MC; Lo Coco F
Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
[TBL] [Abstract][Full Text] [Related]
4. Molecular Genetic Markers in Acute Myeloid Leukemia.
Yohe S
J Clin Med; 2015 Mar; 4(3):460-78. PubMed ID: 26239249
[TBL] [Abstract][Full Text] [Related]
5. [Acute myeloid leukemia].
Döhner K; Paschka P; Döhner H
Internist (Berl); 2015 Apr; 56(4):354-63. PubMed ID: 25787321
[TBL] [Abstract][Full Text] [Related]
6. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
[TBL] [Abstract][Full Text] [Related]
7. Research progress on molecular biomarkers of acute myeloid leukemia.
Yin PY; Wang RW; Jing R; Li X; Ma JH; Li KM; Wang H
Front Oncol; 2023; 13():1078556. PubMed ID: 36824144
[TBL] [Abstract][Full Text] [Related]
8. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies.
Hou HA; Tien HF
J Biomed Sci; 2020 Jul; 27(1):81. PubMed ID: 32690020
[TBL] [Abstract][Full Text] [Related]
9. The challenge of risk stratification in acute myeloid leukemia with normal karyotype.
Zaidi SZ; Owaidah T; Al Sharif F; Ahmed SY; Chaudhri N; Aljurf M
Hematol Oncol Stem Cell Ther; 2008; 1(3):141-58. PubMed ID: 20063545
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia in the era of precision medicine: recent advances in diagnostic classification and risk stratification.
Kansal R
Cancer Biol Med; 2016 Mar; 13(1):41-54. PubMed ID: 27144061
[TBL] [Abstract][Full Text] [Related]
11. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
[TBL] [Abstract][Full Text] [Related]
12. Importance of assessing cytogenetic and molecular risk factors in acute myeloid leukemia therapy.
Coles EC; Colita A; Momanu R; Berbec N; Ivanescu AM; Oprea M; Jardan D; Jardan C; Arghir A; Coriu D; Lupu AR
J Med Life; 2012; 5(Spec Issue):36-43. PubMed ID: 31803284
[TBL] [Abstract][Full Text] [Related]
13. Real-Time Molecular Monitoring in Acute Myeloid Leukemia With Circulating Tumor DNA.
Thakral D; Gupta R; Sahoo RK; Verma P; Kumar I; Vashishtha S
Front Cell Dev Biol; 2020; 8():604391. PubMed ID: 33363162
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal Instability in Acute Myeloid Leukemia.
de Oliveira Lisboa M; Brofman PRS; Schmid-Braz AT; Rangel-Pozzo A; Mai S
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071283
[TBL] [Abstract][Full Text] [Related]
15. Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics.
Marcucci G; Mrózek K; Bloomfield CD
Curr Opin Hematol; 2005 Jan; 12(1):68-75. PubMed ID: 15604894
[TBL] [Abstract][Full Text] [Related]
16. [Molecular Genetic Testing for Acute Myeloid Leukemia].
Janečková V; Semerád L; Ježíšková I; Dvořáková D; Čulen M; Šustková Z; Mayer J; Ráčil Z
Klin Onkol; 2016; 29(6):411-418. PubMed ID: 27951719
[TBL] [Abstract][Full Text] [Related]
17. Acute Myeloid Leukemia-Genetic Alterations and Their Clinical Prognosis.
Lagunas-Rangel FA; Chávez-Valencia V; Gómez-Guijosa MÁ; Cortes-Penagos C
Int J Hematol Oncol Stem Cell Res; 2017 Oct; 11(4):328-339. PubMed ID: 29340131
[TBL] [Abstract][Full Text] [Related]
18. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications.
Yang X; Wong MPM; Ng RK
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527484
[TBL] [Abstract][Full Text] [Related]
19. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
20. Novel Translocation in Acute Myeloid Leukemia: Case Report and Review of Risk-Stratification and Induction Chemotherapy in Patients With Acute Myeloid Leukemia.
Jeha GM; Wesley T; Cataldo VD
J Hematol; 2020 Apr; 9(1-2):13-17. PubMed ID: 32362980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
